Association Between Gut Microbiome and Responses in Melanoma Patients on Anti-PD-1 Therapy


Jennifer Wargo, MD, associate professor of Genomic Medicine and Surgical Oncology, discusses a study that looked at the association of the diversity and composition of the gut microbiome with responses and survival in metastatic melanoma patients on anti-PD-1 therapy.

Related Videos
Related Content